Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343200 · ClinicalTrials.gov registry record · Phase 4
A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.
A Phase 4 study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 4
- Development phase
- 371
- Enrollment target
NCT00343200 is a Phase 4 study that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 371 participants.
The verdict
NCT00343200, a Phase 4 study, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 371 participants
- Enrollment target
Study Summary
To compare the efficacy and safety of Viagra (sildenafil citrate) vs. placebo for the treatment of men with ED and at least 1 prespecified risk factor who do not self identify as having ED.
Interventions
- DRUG Placebo
- DRUG Viagra (sildenafil citrate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343200
The ClinicalTrials.gov registry entry for NCT00343200 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00343200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343200 about?
NCT00343200 is a clinical study titled "A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.". To compare the efficacy and safety of Viagra (sildenafil citrate) vs. placebo for the treatment of men with ED and at least 1 prespecified risk factor who do not self identify as having ED.
What is the current status of trial NCT00343200?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 371 participants. The study started on 2006-07. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00343200?
The interventions under investigation include: Placebo (DRUG), Viagra (sildenafil citrate) (DRUG).
Who is sponsoring clinical trial NCT00343200?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.